A MedPage Today Clinical Challenges series on multiple sclerosis (MS) looked at determining when to stop therapy as patients age, family planning for affected women, and management of radiologically isolated syndrome (RIS).
The following is a three-question quiz to test your knowledge on each aspect of the series. Correct answers and explanations appear after completing the quiz.
Please enable JavaScript to view the
The transaction aims to strengthen Revolution’s parallel development approach to its RAS(ON) inhibitor pipeline in multiple RAS-driven cancers. Credit: Meletios Verras / Shutterstock.com. Revolution Medicines
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes
A world-first discovery has revealed special immune cells called ‘killer T cells’ in older adults, directed against influenza viruses, closely resemble those found in newborns